The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome-Reference-Cited by-同舟云学术

The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome

Published:2013-01-25 Issue:6 Volume:15 Page:513-522
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Jimenez J. G.¹,Rosen J. B.²,Pirags V.³,Massaad R.⁴,Hanson M. E.⁵,Brudi P.⁵,Triscari J.⁵

Affiliation:

1. Hospital CIMA San Jose; Escazu and Universidad de Ciencias Medicas; Sabana Oeste San Jose Costa Rica

2. Clinical Research of South Florida; Coral Gables FL USA

3. Department of Medicine; University of Latvia; Riga Latvia

4. MSD Belgium; Brussels Belgium

5. Merck Sharp & Dohme Corp.; Whitehouse Station NJ USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12059/fullpdf

Reference19 articles.

1. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;N Engl J Med,1998

2. Diabetes and coronary heart disease;Simons;N Engl J Med,1998

3. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults;Am J Clin Nutr,1998

4. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation;Brunzell;Diabetes Care,2008

5. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition;Grundy;Circulation,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of switching from statin-monotherapy to statin/ezetimibe combination therapy on lipid profiles in patients with type 2 diabetes and dyslipidemia: a multicenter open-label study (EUCLID);Vascular Failure;2020-12-21

2. Vascular age;Vnitřní lékařství;2019-12-01

3. Adjuvant Therapy for Incremental Low-Density Lipoprotein Cholesterol Reduction With Ezetimibe;Clinical Medicine Insights: Therapeutics;2017-01

4. All for Statins and Statins for All; An Update;Current Pharmaceutical Design;2015-12-21

5. Effects of Simvastatin and Ezetimibe in Lowering Low-Density Lipoprotein Cholesterol in Subjects with Type 1 and Type 2 Diabetes Mellitus;Metabolic Syndrome and Related Disorders;2015-03